Marseilles, France

Jean-Chretien Noreel


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jean-Chretien Noreel: Innovator in Peripheral Neuropathy Treatment

Introduction

Jean-Chretien Noreel is a notable inventor based in Marseilles, France. He has made significant contributions to the fields of biology, pharmacology, and medicine. His work primarily focuses on the treatment of peripheral neuropathies, which are conditions that affect the peripheral nervous system.

Latest Patents

Noreel holds a patent for "Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same." This invention relates to the use of a cAMP modulator in the preparation of compositions aimed at preventing or treating peripheral neuropathies. The invention is applicable in both human and animal health fields. Additionally, it includes tools and kits designed for the preparation of these compositions. He has 1 patent to his name.

Career Highlights

Throughout his career, Noreel has worked with esteemed institutions such as Université De La Méditerranée and Institut National De La Santé Et De La Recherche Médicale. His research has contributed to advancements in medical treatments and has the potential to improve the quality of life for individuals suffering from peripheral neuropathies.

Collaborations

Some of his notable coworkers include Michel Fontes and Edith Passage. Their collaborative efforts have furthered research in the medical field, particularly in the area of neuropathy treatment.

Conclusion

Jean-Chretien Noreel's innovative work in the treatment of peripheral neuropathies showcases his dedication to advancing medical science. His contributions are significant and have the potential to impact many lives positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…